Toggle light / dark theme

Human-safe drug repairs DNA in a mouse model of Alzheimer’s

While most current Alzheimer’s treatments focus on beta-amyloid plaques, new research targets early-stage DNA damage and chronic neuroinflammation as critical drivers of the disease. In preclinical mouse models, the drug KCL-286 — a compound already proven safe in human spinal cord injury trials — successfully activated DNA repair genes, healed double-strand DNA breaks in neurons, and significantly reduced neuroinflammation. By addressing these foundational pathological processes, KCL-286 has the potential to slow Alzheimer’s progression rather than merely managing symptoms, offering a promising candidate for early or even asymptomatic intervention. Additionally, the article highlights a separate breakthrough in late-stage care, noting that psilocybin successfully restored speech and motor control in a patient after a decade of battling the disease.


A drug, that has previously been shown to be safe and tolerated by humans, reduces multiple disease-linked features of Alzheimer’s in a mouse model of the disease.

New mechanism explains how nerve cells form one long output branch

DZNE researchers have uncovered a mechanism that determines why a neuron usually forms a single, long extension called an “axon”—a phenomenon that is fundamental to how our brain functions. Contrary to the common view that external cues drive axon formation, the team of scientists concluded that its growth originates primarily inside the cell. Their work, based on cell cultures and published in the journal Nature with collaborators from other institutions in Germany, Austria and Japan, reveals how a neuron’s structure is remodeled to generate the axon.

Neurons in the brain and spinal cord form a vast network in which each cell receives many inputs but sends output through only a single, long extension: the axon. “If our neurons had multiple axons, this would cause chaos in the brain,” says Frank Bradke, a neurobiologist and research group leader at DZNE. “Nature has therefore found a clever way to make sure that neurons generate only one axon. This applies not only to humans, but across the entire animal kingdom. So, we’re dealing with very fundamental processes that shape the wiring of the brain and nervous system.”

Mouse study identifies C1 neurons as a driver of prolonged fear and anxiety

Anxiety disorders affect more than 300 million people globally. Several brain regions have been linked to anxiety, but how these regions connect has been poorly understood. By exploring these connections, scientists at St. Jude Children’s Research Hospital revealed that epinephrine-producing C1 neurons in mice modulate fear and anxiety. They found that while the activity of these neurons was normally temporarily elevated in times of stress, prolonged activation led to heightened anxiety that could last many days. Inhibition of C1 neurons reduced anxiety-like behaviors, suggesting these neurons may be worth exploring as therapeutic targets for anxiety disorders. The findings were published today in Neuron.

Anxiety helps us prepare for future threats, but when it is excessive or persistent, it can significantly affect quality of life. Medications exist to alleviate symptoms but can have off-target effects that might discourage long-term use. By identifying C1 neurons as novel modulators of fear and anxiety, Lindsay Schwarz, Ph.D., Department of Developmental Neurobiology, is hopeful that these cells could serve as a new therapeutic target for anxiety-related disorders.

“C1 neurons appear to promote anxiety without directly affecting autonomic functions,” Schwarz said. “This suggests they may be a better target than broadly affecting signaling across the entire brain and body.”

Researchers Discovered Your Brain Really Can Sync Up With Someone Else’s. Here’s How It Works

If you’ve ever been riding a wave of creativity that feels like your brain and someone else’s have been Bluetooth-synced and are now finishing each other’s sentences, both instinctively knowing where the song/screenplay/woodworking project or whatever you’re building should go, then you’ve experienced what scientists call brain synchrony.

As described by a team of researchers publishing their findings as a press release on Eureka Alert, originally published in Trends in Cognitive Sciences, it’s a real phenomenon that’s been observed in laboratories and real-world settings. Now, researchers say it isn’t just measurable, but it can actually be strengthened.

Researchers reviewed a decade of studies involving thousands of people, from regular everyday students to professional artists. Using portable EEG headsets, researchers found that when people are genuinely engaged with one another, their brainwave activity begins to align. Even more interesting, when participants received real-time feedback showing how synchronized they were, that alignment often became even stronger.

The S1–insula Circuit Differentially Modulates Alcohol Drinking and Aversive Behavior in Mice

Sensory processing assigns salience to environmental and internal stimuli, shaping behavior through learned associations. In alcohol use disorder (AUD), sensory cue processing is dysregulated, driving problematic drinking patterns and hyperkatifeia in abstinence. While visual, olfactory, and taste cues are known to influence AUD progression, the neurocircuit mechanisms that regulate sensory information in addiction remain poorly understood. The primary somatosensory cortex (S1) encodes tactile, thermal, proprioceptive, and nociceptive inputs and projects to higher-order regions involved in motor and emotional processing. One such target is the insula, a hub for interoceptive integration and affective regulation. We previously identified that insula neurons receiving S1 projections in turn extend into the extended amygdala, implicating this projection in emotional processing.

Does time come from the entire universe running computations?

Explaining the passage of time has been a gnarly problem in physics basically forever, but physicist and computer scientist Stephen Wolfram has a radical proposal for where it comes from. He discussed his ideas on time – and what they mean for free will – with reporter Leah Crane

Frank Visser / ChatGPT

With the death of Ervin Laszlo at the age of 94, the world has lost one of the twentieth and twenty-first centuries’ most prolific advocates of holistic thinking. Philosopher, systems theorist, futurist, concert pianist, and founder of multiple international organizations, Laszlo spent decades arguing that humanity needed a new worldview—one capable of integrating science, ecology, ethics, and spirituality into a coherent vision.

Although many of his more speculative ideas remain controversial, his broader contribution to systems thinking and global consciousness deserves serious attention. Few intellectuals worked as tirelessly to bridge disciplinary divides or to communicate the urgency of planetary interconnectedness.

My podcast episode of Frameshifts is now available!

🧬 Benjamin Arya interviews me about my research on gene therapy delivery systems, about my first startup company Cathedral Therapeutics (see link to website and a bit about my newer venture towards solving the brain delivery problem.


“Putting an AAV inside of a protein vault shields the AAV from the preexisting antibodies that humans produce.”

/* */